Our cover story this week tracks recent developments in cancer treatment and how inroads in immunity could be a game-changer

In what could be a game-changer, Moderna and Merck announced the first-ever positive results from a Phase III trial to combat melanoma

This killer disease evolves to hide and avoid detection from the cells that would destroy it, but as recent trials show, scientists are wising up to cancer's defences

The sense that the US may be less committed to its allies' security is prompting a rethink of long-held assumptions, much to the delight of China and Russia

Supporting Israel used to help politicians get elected, but with Americans far more critical of Tel Aviv's influence on US policy, it has now become a liability at the ballot box

Global competition is no longer about currencies alone, but about the channels through which money and data move and China and Brazil are testing the limits of Western dominance

In an interview with Al Majalla, CENTCOM spokesman Tim Hawkins details what the US has achieved vis-a-vis Trump's maximum pressure campaign on Tehran and its regional proxies

Tactical excellence can never salvage strategic incompetence

His latest tariff threats are proportionate. But the situation could escalate